Jpmorgan Chase & CO Trans Medics Group, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 412,497 shares of TMDX stock, worth $52.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
412,497
Previous 256,826 60.61%
Holding current value
$52.4 Million
Previous $16 Million 73.31%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$56.73 - $79.42 $8.83 Million - $12.4 Million
155,671 Added 60.61%
412,497 $27.8 Million
Q4 2024

Feb 12, 2025
BUY
$59.28 - $144.9 $3.34 Million - $8.17 Million
56,398 Added 28.14%
256,826 $16 Million
Q3 2024

Dec 26, 2024
SELL
$135.68 - $176.11 $1.95 Million - $2.53 Million
-14,365 Reduced 6.69%
200,428 $31.5 Million
Q3 2024

Nov 08, 2024
SELL
$135.68 - $176.11 $1.95 Million - $2.53 Million
-14,365 Reduced 6.69%
200,428 $31.5 Million
Q2 2024

Dec 26, 2024
BUY
$72.62 - $150.62 $1.04 Million - $2.16 Million
14,365 Added 7.17%
214,793 $32.4 Million
Q2 2024

Aug 12, 2024
BUY
$72.62 - $150.62 $7.63 Million - $15.8 Million
105,052 Added 95.73%
214,793 $32.4 Million
Q1 2024

Dec 26, 2024
SELL
$70.86 - $89.93 $6.43 Million - $8.16 Million
-90,687 Reduced 45.25%
109,741 $8.11 Million
Q1 2024

May 10, 2024
SELL
$70.86 - $89.93 $469,376 - $595,696
-6,624 Reduced 5.69%
109,741 $8.11 Million
Q4 2023

Dec 26, 2024
SELL
$36.74 - $81.08 $3.09 Million - $6.82 Million
-84,063 Reduced 41.94%
116,365 $9.18 Million
Q4 2023

Feb 12, 2024
SELL
$36.74 - $81.08 $929,779 - $2.05 Million
-25,307 Reduced 17.86%
116,365 $9.18 Million
Q3 2023

Nov 14, 2023
BUY
$53.47 - $96.07 $1.63 Million - $2.93 Million
30,486 Added 27.42%
141,672 $7.76 Million
Q2 2023

Aug 11, 2023
BUY
$66.23 - $88.73 $762,373 - $1.02 Million
11,511 Added 11.55%
111,186 $9.34 Million
Q1 2023

May 18, 2023
BUY
$53.63 - $82.33 $2.09 Million - $3.21 Million
39,008 Added 64.3%
99,675 $7.55 Million
Q1 2023

May 11, 2023
BUY
$53.63 - $82.33 $1.54 Million - $2.37 Million
28,745 Added 90.05%
60,667 $4.59 Million
Q4 2022

Feb 13, 2023
BUY
$39.08 - $64.29 $144,908 - $238,387
3,708 Added 13.14%
31,922 $1.97 Million
Q3 2022

Nov 14, 2022
SELL
$31.56 - $55.75 $1.22 Million - $2.15 Million
-38,513 Reduced 57.72%
28,214 $1.18 Million
Q2 2022

Aug 11, 2022
BUY
$20.56 - $32.15 $1.11 Million - $1.73 Million
53,960 Added 422.65%
66,727 $2.1 Million
Q1 2022

May 11, 2022
BUY
$12.58 - $26.94 $32,594 - $69,801
2,591 Added 25.46%
12,767 $343,000
Q4 2021

Feb 10, 2022
BUY
$19.16 - $32.68 $8,986 - $15,326
469 Added 4.83%
10,176 $194,000
Q3 2021

Nov 12, 2021
BUY
$25.92 - $34.51 $251,605 - $334,988
9,707 New
9,707 $322,000

Others Institutions Holding TMDX

# of Institutions
338
Shares Held
32.1M
Call Options Held
852K
Put Options Held
690K
View Full List

About TransMedics Group, Inc.

TMDX Quotes by TradingView
  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $4.05B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email